Drug-Repositioning Screens Identify Triamterene as a Selective Drug for the Treatment of DNA Mismatch Repair Deficient Cells
View/ Open
Volume
23
Pagination
2880 - 2890
DOI
10.1158/1078-0432.CCR-16-1216
Journal
CLINICAL CANCER RESEARCH
Issue
ISSN
1078-0432